Menu
Home

CancerLinQ is growing in all regions and across settings of care. We are making significant investments in new solutions that progress and extend beyond our automated quality solutions, into automated notifications of potentially beneficial diagnostics and treatments, patient-to-trial matching solutions, and advanced AI SaaS analytics solutions for all members.

Robert Miller,
Chief Medical Science Officer

Robert Miller
I want to see a demo!

Did you miss the interviews?

We had some great sessions in our booth at Annual Meeting, sharing the vision for ConcertAI and CancerLinQ and featuring some of our practices' journeys with CancerLinQ. Catch the replays below.

Factsheets

Interested in learning more? Please click the factsheet you are interested in downloading.

SmartLinQ Cover
RxLinQ Cover
TrialLinQ Cover
View All CancerLinQ Publications
CLQ ASCO Publications v2 -4169

Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis

Abstract:4169 | Poster Bd#: 149

Authors:

Kaleem Ahmed, Sheriff Issaka, Clayton Marcinak, Syed Nabeel Zafar

 

Organizations:

Department of Surgery, University of Wisconsin - Madison, Department of Surgery, University of Wisconsin–Madison, Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison

 

Learn More
CLQ ASCO Publications v2 -e23237

Electronic clinical quality measure (eCQM) concordance and quality care disparities among patients with breast cancer (BC)

Abstract: e23237 | Publication Only

Authors:

Nehanda Jones, Elizabeth Lipschultz, Adam Blair, Brooke Smither, Jacob Koskimaki, Robert Miller

 

Organizations:

CancerLinQ

 

Learn More
CLQ ASCO Publications v2 -e13739

Disparities in patients with HER2-positive breast cancer receiving optimal treatment: Analysis of the real-world ASCO CancerLinQ dataset

Abstract: e13739 | Publication Only

Authors:

Olga Kantor, Alyssa Jones, Erica Mayer, Mariana Chavez-MacGregor, Tari King, Elizabeth Mittendorf

 

Organizations:

Brigham and Women's Hospital, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center

Learn More